March 2023
192 articles-
Mar 31 · 03:29Biotechnology Daily
By merging with struggling Erytech, Pherecydes spies opportunity to boost AMR strategy
-
Mar 31 · 03:28Biotechnology Daily
Theratechnologies assembles science team to retool solid tumor trial after clinical hold
-
Mar 31 · 03:27Biotechnology Daily
GE HealthCare lands Class I recall for 1,200-pound scanners at risk of falling onto patients
-
Mar 31 · 03:25Biotechnology Daily
Newron's shares accelerate as one-year schizophrenia data boost chances of historic approval
-
Mar 31 · 03:23Bio Business News
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
-
Mar 31 · 03:21Bio Business News
Insulet doubles down with another $25M automated insulin delivery tech buy
-
Mar 31 · 03:20Bio Business News
On hunt for better gene med delivery, Aera exits stealth with $193M and Alnylam vet at helm
-
Mar 31 · 03:18Bio Business News
Merck KGaA, spying a major market, pays Aqilion €10M to tackle tough autoimmune target
-
Mar 30 · 02:51Biotechnology Daily
GSK vaccine R&D head touts consistency of RSV data but is mum on restarting maternal trial
-
Mar 30 · 02:50Biotechnology Daily
Concert persuades FDA to keep breakthrough tag for alopecia therapy despite Lilly's arrival
-
Mar 30 · 02:49Biotechnology Daily
AlloVir's cell therapy tackles infection in midphase kidney transplant trial
-
Mar 30 · 02:48Biotechnology Daily
Tasso lassos EU approval for at-home high-volume blood collection device
-
Mar 30 · 02:46Bio Business News
Arrowhead’s $3.7B J&J deal is done, CEO says, after ‘out of the blue’ NASH decision
-
Mar 30 · 02:45Bio Business News
Titan Medical, already down to bare bones, lays off almost half of executive team
-
Mar 30 · 02:43Bio Business News
Biogen's brand-new CEO shuns 'desperation factor' but signals major business development ahead
-
Mar 30 · 02:42Bio Business News
Biogen bails on BTK race just 19 months after placing $125M bet
-
Mar 30 · 02:01Market Watch
Bluebird Bio Shares Down After Fourth-Quarter-Revenue Decline
-
Mar 29 · 00:32Biotechnology Daily
Pharnext ditches Alzheimer's plans, saying more development would be too costly
-
Mar 29 · 00:31Biotechnology Daily
Sesen sweetens Carisma deal to win over rogue investors in time for Valentine's Day
-
Mar 29 · 00:29Biotechnology Daily
Vicarious Surgical lays off 14% of workers to get its VR-powered robotics'out the door fast'
-
Mar 29 · 00:28Biotechnology Daily
Broad ALS targets show signs of success in treating genetic and sporadic forms
-
Mar 29 · 00:25Bio Business News
Replay rolls again, creating TCR-NK cell therapy startup with MD Anderson to close in on clinic
-
Mar 29 · 00:24Bio Business News
New biotech VC takes off with $520M and a flight deck stacked with big-name investors ready to serve
-
Mar 29 · 00:22Bio Business News
Soligenix's stock sinks 38% after FDA refuses to consider lymphoma therapy application